By Zelira TherapeuticsNovember 13, 2018 Cleansing Notice and Appendix 2A02/24/2021Appendix 4D & FY21 Interim Financial Report02/22/2021Strategic Transition and Executive Changes02/15/2021US National Cannabis Roundtable appoints Zelira as Director02/11/2021Appendix 4C – quarterly01/29/2021